Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meniere Disease | 6 | 2022 | 31 | 3.870 |
Why?
|
| Dizziness | 9 | 2021 | 27 | 3.780 |
Why?
|
| Migraine Disorders | 6 | 2021 | 66 | 3.050 |
Why?
|
| Cochlear Implantation | 6 | 2022 | 99 | 2.460 |
Why?
|
| Cognitive Dysfunction | 4 | 2021 | 176 | 2.330 |
Why?
|
| Vestibular Diseases | 5 | 2020 | 11 | 2.300 |
Why?
|
| Hearing Loss, Sensorineural | 5 | 2022 | 110 | 2.030 |
Why?
|
| Ear, Inner | 4 | 2022 | 47 | 1.590 |
Why?
|
| Cochlear Implants | 6 | 2022 | 110 | 1.590 |
Why?
|
| Hearing Loss | 4 | 2022 | 154 | 1.530 |
Why?
|
| Temporal Bone | 7 | 2022 | 53 | 1.530 |
Why?
|
| Vestibule, Labyrinth | 2 | 2021 | 19 | 1.480 |
Why?
|
| Vertigo | 5 | 2021 | 24 | 1.390 |
Why?
|
| Speech Perception | 3 | 2022 | 261 | 1.140 |
Why?
|
| Quality of Life | 5 | 2021 | 1515 | 1.060 |
Why?
|
| Ear Diseases | 4 | 2020 | 37 | 1.050 |
Why?
|
| Skull Base | 5 | 2018 | 72 | 1.030 |
Why?
|
| Neurotology | 3 | 2018 | 7 | 0.960 |
Why?
|
| Hearing | 3 | 2022 | 133 | 0.920 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2020 | 6 | 0.910 |
Why?
|
| Tinnitus | 2 | 2020 | 22 | 0.880 |
Why?
|
| Travel-Related Illness | 1 | 2023 | 2 | 0.880 |
Why?
|
| Quality Improvement | 4 | 2021 | 413 | 0.840 |
Why?
|
| Osteomyelitis | 1 | 2022 | 40 | 0.830 |
Why?
|
| Endolymphatic Hydrops | 1 | 2022 | 4 | 0.820 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 3 | 2016 | 15 | 0.800 |
Why?
|
| Humans | 50 | 2023 | 68618 | 0.790 |
Why?
|
| Vestibular Function Tests | 1 | 2020 | 5 | 0.730 |
Why?
|
| Semicircular Canals | 2 | 2020 | 9 | 0.730 |
Why?
|
| Laryngectomy | 1 | 2020 | 30 | 0.720 |
Why?
|
| Cochlear Nerve | 1 | 2020 | 83 | 0.690 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.670 |
Why?
|
| Treatment Outcome | 17 | 2022 | 7029 | 0.660 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.580 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 142 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.580 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 42 | 0.570 |
Why?
|
| Pandemics | 1 | 2020 | 352 | 0.550 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 3 | 2020 | 6 | 0.540 |
Why?
|
| Reoperation | 2 | 2016 | 467 | 0.530 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2800 | 0.510 |
Why?
|
| Round Window, Ear | 1 | 2015 | 8 | 0.500 |
Why?
|
| Ear | 1 | 2015 | 12 | 0.500 |
Why?
|
| Cochlea | 4 | 2017 | 169 | 0.490 |
Why?
|
| Female | 25 | 2022 | 38074 | 0.450 |
Why?
|
| Nasopharyngeal Diseases | 1 | 2013 | 2 | 0.440 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2013 | 8 | 0.430 |
Why?
|
| Trigeminal Nerve | 1 | 2013 | 22 | 0.430 |
Why?
|
| Adult | 18 | 2021 | 21403 | 0.430 |
Why?
|
| Middle Aged | 16 | 2022 | 21147 | 0.400 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2011 | 12 | 0.390 |
Why?
|
| Retrospective Studies | 11 | 2021 | 7277 | 0.390 |
Why?
|
| Desensitization, Immunologic | 1 | 2011 | 25 | 0.380 |
Why?
|
| Drug Hypersensitivity | 1 | 2011 | 35 | 0.380 |
Why?
|
| Presbycusis | 1 | 2012 | 84 | 0.370 |
Why?
|
| Male | 23 | 2021 | 37321 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2018 | 2324 | 0.370 |
Why?
|
| Epiglottis | 1 | 2010 | 11 | 0.360 |
Why?
|
| Obesity | 5 | 2018 | 1076 | 0.350 |
Why?
|
| Aspirin | 1 | 2011 | 295 | 0.340 |
Why?
|
| Rhinitis | 2 | 2012 | 383 | 0.340 |
Why?
|
| Dilatation | 2 | 2020 | 58 | 0.330 |
Why?
|
| Eustachian Tube | 2 | 2020 | 31 | 0.330 |
Why?
|
| Aged | 13 | 2021 | 14862 | 0.330 |
Why?
|
| Sinusitis | 2 | 2012 | 432 | 0.330 |
Why?
|
| Prognosis | 3 | 2022 | 2093 | 0.290 |
Why?
|
| Risk Assessment | 4 | 2018 | 2007 | 0.270 |
Why?
|
| Child, Preschool | 5 | 2017 | 3187 | 0.250 |
Why?
|
| Cohort Studies | 3 | 2021 | 2358 | 0.250 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2018 | 32 | 0.230 |
Why?
|
| Hearing Tests | 2 | 2020 | 70 | 0.220 |
Why?
|
| Rehabilitation | 1 | 2023 | 29 | 0.210 |
Why?
|
| Paralysis | 1 | 2022 | 35 | 0.210 |
Why?
|
| Neurotransmitter Agents | 1 | 2023 | 102 | 0.210 |
Why?
|
| Psoriasis | 1 | 2022 | 46 | 0.200 |
Why?
|
| Physical Therapy Modalities | 1 | 2023 | 133 | 0.200 |
Why?
|
| Patient Acuity | 1 | 2021 | 17 | 0.200 |
Why?
|
| Otologic Surgical Procedures | 1 | 2021 | 23 | 0.190 |
Why?
|
| Postoperative Complications | 4 | 2017 | 1615 | 0.190 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 3259 | 0.190 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2022 | 96 | 0.180 |
Why?
|
| Head Impulse Test | 1 | 2020 | 2 | 0.180 |
Why?
|
| Return to Work | 1 | 2020 | 6 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2020 | 3705 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 2223 | 0.180 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 123 | 0.180 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 27 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 40 | 0.180 |
Why?
|
| Translating | 1 | 2019 | 23 | 0.170 |
Why?
|
| Nasal Polyps | 2 | 2012 | 184 | 0.170 |
Why?
|
| Infant | 2 | 2017 | 2891 | 0.170 |
Why?
|
| Disinfection | 1 | 2020 | 112 | 0.170 |
Why?
|
| Counseling | 1 | 2021 | 280 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2021 | 311 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.160 |
Why?
|
| Vestibular Neuronitis | 1 | 2018 | 2 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 4848 | 0.160 |
Why?
|
| Language | 1 | 2019 | 120 | 0.160 |
Why?
|
| Comorbidity | 1 | 2022 | 1426 | 0.160 |
Why?
|
| Neurology | 1 | 2018 | 43 | 0.150 |
Why?
|
| Bone Density | 1 | 2018 | 159 | 0.150 |
Why?
|
| Otolaryngology | 1 | 2018 | 38 | 0.150 |
Why?
|
| Facial Nerve | 1 | 2017 | 25 | 0.150 |
Why?
|
| Speech Production Measurement | 1 | 2017 | 14 | 0.150 |
Why?
|
| Anus, Imperforate | 1 | 2017 | 3 | 0.140 |
Why?
|
| Ectodermal Dysplasia | 1 | 2017 | 8 | 0.140 |
Why?
|
| Growth Disorders | 1 | 2017 | 21 | 0.140 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 2279 | 0.140 |
Why?
|
| Hypothyroidism | 1 | 2017 | 24 | 0.140 |
Why?
|
| Pancreatic Diseases | 1 | 2017 | 66 | 0.140 |
Why?
|
| Publishing | 1 | 2018 | 89 | 0.140 |
Why?
|
| Patient Safety | 1 | 2018 | 202 | 0.140 |
Why?
|
| Intracranial Hypertension | 1 | 2017 | 53 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 129 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1851 | 0.140 |
Why?
|
| Ossicular Replacement | 1 | 2016 | 7 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2018 | 403 | 0.130 |
Why?
|
| Otitis Media | 1 | 2016 | 35 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1553 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2017 | 114 | 0.130 |
Why?
|
| Thyroidectomy | 2 | 2012 | 31 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.130 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 95 | 0.120 |
Why?
|
| Ear Neoplasms | 1 | 2015 | 13 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2015 | 32 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 36 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 40 | 0.120 |
Why?
|
| Otitis Externa | 1 | 2014 | 14 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 756 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 98 | 0.120 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 85 | 0.120 |
Why?
|
| Aneurysm, False | 1 | 2014 | 60 | 0.110 |
Why?
|
| Foramen Ovale | 1 | 2013 | 1 | 0.110 |
Why?
|
| Choristoma | 1 | 2013 | 20 | 0.110 |
Why?
|
| Bone Diseases | 1 | 2013 | 20 | 0.110 |
Why?
|
| Cavernous Sinus | 1 | 2013 | 10 | 0.110 |
Why?
|
| Prednisone | 1 | 2013 | 104 | 0.110 |
Why?
|
| Radiotherapy Dosage | 1 | 2013 | 125 | 0.110 |
Why?
|
| Young Adult | 4 | 2018 | 5717 | 0.110 |
Why?
|
| Neuroglia | 1 | 2013 | 136 | 0.100 |
Why?
|
| Hair Cells, Vestibular | 1 | 2012 | 6 | 0.100 |
Why?
|
| Embolization, Therapeutic | 1 | 2014 | 150 | 0.100 |
Why?
|
| Parathyroid Neoplasms | 1 | 2012 | 13 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 1 | 2012 | 12 | 0.100 |
Why?
|
| Organ of Corti | 1 | 2012 | 21 | 0.100 |
Why?
|
| Autoradiography | 1 | 2012 | 94 | 0.100 |
Why?
|
| Stria Vascularis | 1 | 2012 | 31 | 0.100 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2012 | 19 | 0.100 |
Why?
|
| Neck Dissection | 1 | 2012 | 55 | 0.100 |
Why?
|
| Parathyroid Glands | 1 | 2012 | 22 | 0.100 |
Why?
|
| Length of Stay | 1 | 2015 | 780 | 0.100 |
Why?
|
| Thyroid Diseases | 1 | 2012 | 33 | 0.100 |
Why?
|
| Atrophy | 1 | 2012 | 112 | 0.100 |
Why?
|
| Spiral Ganglion | 1 | 2012 | 47 | 0.100 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 40 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 2012 | 67 | 0.100 |
Why?
|
| Drainage | 1 | 2012 | 133 | 0.100 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 117 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 219 | 0.100 |
Why?
|
| Auditory Threshold | 1 | 2012 | 206 | 0.100 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 68 | 0.100 |
Why?
|
| Time Factors | 2 | 2017 | 4655 | 0.090 |
Why?
|
| Child | 2 | 2020 | 6405 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 234 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2016 | 1330 | 0.090 |
Why?
|
| Prevalence | 3 | 2021 | 1619 | 0.090 |
Why?
|
| Pneumonia, Aspiration | 1 | 2010 | 22 | 0.090 |
Why?
|
| Fundoplication | 1 | 2010 | 27 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2010 | 41 | 0.090 |
Why?
|
| Mucormycosis | 1 | 2009 | 6 | 0.090 |
Why?
|
| Laryngoscopy | 1 | 2010 | 61 | 0.090 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2009 | 30 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 109 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2010 | 110 | 0.080 |
Why?
|
| Algorithms | 1 | 2014 | 1196 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 929 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1140 | 0.080 |
Why?
|
| Neurons | 1 | 2013 | 881 | 0.070 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 378 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2021 | 238 | 0.050 |
Why?
|
| Otoscopy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2020 | 328 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 214 | 0.040 |
Why?
|
| Encephalocele | 1 | 2017 | 30 | 0.040 |
Why?
|
| Pseudotumor Cerebri | 1 | 2017 | 43 | 0.030 |
Why?
|
| Health Surveys | 1 | 2018 | 489 | 0.030 |
Why?
|
| Bone Conduction | 1 | 2016 | 9 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5731 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 622 | 0.030 |
Why?
|
| Facial Muscles | 1 | 2015 | 11 | 0.030 |
Why?
|
| Titanium | 1 | 2016 | 118 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1266 | 0.030 |
Why?
|
| United States | 2 | 2018 | 7367 | 0.030 |
Why?
|
| Angiography | 1 | 2014 | 194 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1864 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 572 | 0.030 |
Why?
|
| Lost to Follow-Up | 1 | 2012 | 7 | 0.030 |
Why?
|
| Registries | 1 | 2015 | 733 | 0.030 |
Why?
|
| Neck | 1 | 2012 | 62 | 0.030 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2012 | 62 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 1603 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 867 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 649 | 0.020 |
Why?
|
| Debridement | 1 | 2009 | 55 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2009 | 55 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2009 | 55 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 164 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2009 | 108 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1038 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 8912 | 0.020 |
Why?
|